ArticleWorld journal of gastroenterology2025

Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model.

Luciano PirolaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.